Bioventus Inc. - SIC # 3840 -

Ticker Exchange SIC # Website Latest Ticker
BVS Nasdaq 3840 www.bioventus.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Bioventus Inc.

Is It Too Late To Consider Buying Bioventus Inc. (NASDAQ:BVS)? - Dec 4th, 2025 4:41 am
Bioventus to Present at the Piper Sandler 37th Annual Healthcare Conference - Nov 25th, 2025 2:15 pm
Bioventus Inc. Just Recorded A 36% EPS Beat: Here's What Analysts Are Forecasting Next - Nov 7th, 2025 3:55 am
Bioventus (BVS): One-Off $17.3M Loss Challenges Bullish Narratives After Profitability Milestone - Nov 4th, 2025 8:19 pm
Bioventus Inc (BVS) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amid Market Challenges - Nov 4th, 2025 2:08 pm
Bioventus: Q3 Earnings Snapshot - Nov 4th, 2025 5:44 am
Bioventus Reports Third Quarter Financial Results - Nov 4th, 2025 5:30 am
Bioventus to Report Third Quarter of Fiscal Year 2025 Financial Results on November 4, 2025 - Oct 28th, 2025 5:00 am
Should You Be Worried About Bioventus Inc.'s (NASDAQ:BVS) 1.3% Return On Equity? - Sep 24th, 2025 4:03 am
Bioventus to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference - Sep 3rd, 2025 5:30 am
Shareholders Can Be Confident That Bioventus' (NASDAQ:BVS) Earnings Are High Quality - Aug 14th, 2025 5:01 am
Craig-Hallum Reiterates a Buy Rating on Bioventus (BVS), Sets a $15 PT - Aug 13th, 2025 10:08 am
Bioventus Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year - Aug 9th, 2025 6:44 am
Bioventus to Present at the Canaccord Genuity 45th Annual Global Growth Conference - Aug 7th, 2025 2:15 pm
Bioventus Second Quarter 2025 Earnings: Beats Expectations - Aug 7th, 2025 5:58 am
Bioventus (BVS) Misses Q2 Earnings and Revenue Estimates - Aug 6th, 2025 6:55 am
Bioventus: Q2 Earnings Snapshot - Aug 6th, 2025 5:52 am
Bioventus Reports Second Quarter Financial Results - Aug 6th, 2025 5:00 am
Bioventus Enters into a New $400 Million Senior Secured Credit Agreement Lowering Interest Expense and Providing Increased Liquidity - Aug 4th, 2025 6:00 am
Bioventus Receives FDA 510(k) Clearances for two Next-Generation Peripheral Nerve Stimulation Products - Jul 30th, 2025 5:30 am